Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-10-04
2005-10-04
Helms, Larry R. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S388260, C424S139100, C424S141100, C424S146100
Reexamination Certificate
active
06951923
ABSTRACT:
This invention provides for antibodies directed to OLD-35 protein, the product of the OLD-35 gene, which displays enhanced expression during cellular senescence and terminal cell differentiation.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5200313 (1993-04-01), Carrico
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5710137 (1998-01-01), Fisher
patent: 6020172 (2000-02-01), Both
patent: WO 99/25878 (1999-05-01), None
patent: PCT/US00/02920 (2000-02-01), None
Benjamin L. E. et al. 1998, Development 125:1591-1598.
Vukicevic S. et al. 1996, PNAS USA 93:9021-9026.
Massague J. 1987, Cell 49:437-438.
Pilbeam C. C. et al. 1993, Bone 14:717-720.
Skolnick J. et al. 2000, Trends in Biotech. 18:34-39.
Smith et al. 1997, Nature Biotechnology 15:1222-1223.
Brenner. 1999, Trends in Genetics 15:132-133.
Fu et al. EMBO Journal, 1996, vol. 15, pp. 4392-4401.
Powell et al. Pharmacogenetics, 1998, vol. 8, pp. 411-421.
Vallejo et al. Biochimie, 2000, vol. 82, pp. 1129-1133.
Jang et al. Clinical and Experimental Metastasis, 1997, vol. 15, pp. 469-483.
Yehudai-resheff et al. 2001, Mol. Cell. Biol. 21(6):5408-5416.
Accorsi A. et al. 1991, Biochem. Int. 24(1):23-31.
Lewin B. Genes VI, 1997, CH. 29, pp. 847-848.
Leszczyniecka M, Su Z, Kang D, Sarkar D, Fisher PB (2003). Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPase(old-35), a Type I interferon inducible early response gene.Gene316:143-156.
Sarkar D, Leszczyniecka M, Kang DC, Lebedeva IV, Valerie K, Dhar S, Pandita TK, Fisher PB (2003). Down-regulation of Myc as a potential target for growth arrest induced by human polynucleotide phosphorylase (hPNPaseold-35) in human melanoma cells.J Biol Chem.278(27):24542-24551.
Strausberg R (2003). Homo sapiens polyribonucleotide nucleotidyltransferase 1, mRNA (cDNA clone MGC:61565 Image:6062060), complete cds. GenBank Acc. No. BC053660.
Takahashi H, Furukawa T, Yano T (2003). Homo sapiens PNPase mRNA, partial cds. GenBank Acc. No. AY290863.
Leszczyniecka M, Kang DC, Sarkar D, Su ZZ, Holmes M, Valerie K, Fisher PB (2002). Identification and cloning of human polynucleotide phosphorylase, hPNPase old-35, in the context of terminal differentiation and cellular senescence.Proc Natl Acad Sci USA99(26):16636-16641.
Leszczyniecka et al.(2002), GenBank Acc. No. AY027528.
Raijmakers R (2002). Homo sapiens mRNA for polynucleotide phosphorylase-like protein (PNPase gene). GenBank Acc. No. AJ458465.
(Oct. 16, 2001), GenBank Acc. No. P50849.
Madireddi MT, Dent P, Fisher PB (2000. Regulation of mda-7 gene expression during human melanoma differentiation.OncogeneMar. 2, 2000;19(10):1362-1368.
Rosenberg LE, Schechter AN (2000). Gene therapist, heal thyself.Science287:1751.
Strausberg R (2000). Homo sapiens polyribonucleotide nucleotidyltransferase 1 mRNA. GenBank Acc. No. BC000862.
Antic D, Lu N, Keene JD (1999). ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurties in human teratocarcinoma cells.Genes Dev13:449-461.
Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB (1999). Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells.Oncogene 18(23):3546-3552.
Leszczyniecka M. (Feb. 2, 1999), Keystone Symposium “Aging and Environmental Influences on Life Span,” Feb. 2-7, 1999 (submitted abstract).
Roberts PJ, Mollapour E, Watts MJ, Linch DC (1999). Primitive myeloid cells express high levels of phospholipase A2 activity in the absence of leukotriene release:selective regulation by stem cell factor involving the MAP kinase pathway.Blood94:1261-1272.
Wynford-Thomas (Jan. 1999). Cellular sensescence and cancer.J. Pathol. 187():100-111.
Branch A (1998). A good antisense is hard to find.TIBS23:45-50.
Der SD, Zhou A, Williams BR, Silverman RH (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.Proc Natl Acad Sci USA95:15623-15628.
Gire V, Wynford-Thomas D (1998). Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies.Mol Cell Biol 18(3):1611-1621.
Gonos et al. (Apr. 1998). Cloning and identification of genes that associate with mammalian replicative senescence.Exp. Cell Res. 240(1):66-74.
Lin JJ, Jiang H, Fisher PB (1998). Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene.Gene207(2):105-110.
Niculescu AB 3rd, Chen X, Smetts M, Hengst L, Prives C, Reed SI (1998). Effects of p21 (Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.Mol Cell Biol 18(1):629-643.
Spicher A, Guicherit OM, Duret L, Aslanian A, Sanjines EM, Denko NC, Giaccia AJ, Blau HM (1998). Highly conserved RNA sequences that are sensors of environmental stress.Mol Cell Biol18:7371-7382.
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998). How cells respond to interferons.Ann Rev. Biochem 67:227-264.
Zhang P, Vigne JL, Mellon SH (1998). Polyribonucleotide phosphorylase is a double-stranded DNA-binding protein.DNA Cell Biol 17(2):169-175.
Antic D, Keene JD (1997). Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet. 61:273-278.
Blum, E, Py B, Carpousis AJ, Higgins CF (1997). Polyphosphate kinase is a component of theEscherichia coliRNA degradosome.Mol Microbiol 26(2):387-398.
Gura T (1997). Systems for identifying drugs are often faulty.Science278(5340):1041-1042.
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998). How cells respond to interferons.Ann Rev. Biochem 67:227-264.
Strausberg (Jun. 1998), EST ov80.eo5.sl, GenBank Acc. No. AI023627.
Zhang P, Vigne JL, Mellon SH (1998). Polyribonucleotide phosphorylase is a double-stranded DNA-binding protein.DNA Cell Biol. 17(2):169-175.
Myer VE, Fan XC, Steitz JA (1997). Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay.EMBO J16(8):2130-2139.
Strausberg R (1997). EST nf94c12.sl. GenBank Acc. No. AA535914.
Strausberg R (1997). EST zs13d08.rl. Gen Bank Acc. No. AA252572.
Wilson RK (1997). EST zq51b10.rl. Gen Bank Acc. No. AA206675.
Verman IM, Somia N (1997). Gene therapy—promises, problems and prospects.Nature389(6648):239-242.
Agrawal S (1996). Antisense oligonucleotides:towards clinical trials.TIBTECH14:376-387.
Campisi J (1996). Replicative senescence: an old lives' tale?Cell84(4):497-500.
Hayes R, Kudla J. Schuster G, Gabay L, Maliga P, Gruissem W (1996). chloroplast mRNA 3′-end processing by a high molecular weight protein complex is regulated by nuclear encoded RNA binding proteins.EMBO J15:1132-1141.
Holt SE, Wright WE, Shay JW (1996). Regulation of telomerase activity in immortal cell lines.Mol Cell Biol 16(6):2932-2939.
Hudson (Jun. 1996), human STS EST127457, GenBank Acc. No. G26100.
Hudson (Jun. 1996), human STS EST324915, GenBank Acc. No. G25452.
Lacombe L, Orlow I, Silver D, Gerald WL, Fair WR, Reuter VE, Cordon-Cardo C (1996). Analysis of p21 WAF1/CIP1 in primary bladder tumors.Oncol Res 8(10-11):409-414.
Ledley FD (1996). Pharmaceutical Approach to somatic gene therapy.Pharmaceutical Research13:1595-1614.
Lin JJ, Jiang H, Fisher PB (1996). Characterization of a novel melanoma differentiation associated gene, mda-9, that is down-regulated during terminal cell differentiation.Mol Cell Different 4(4):317-333.
Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM (1996). A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.Genes Dev 10(8):934-947.
Luttinger A, Hahn J, Dubnau D. Polynucleotide phosphorylase is necessary for competence development inBacillus subtilis. Mol Microbiol19(2):343-356.
Luttinger et al. (Feb. 1996), GenBank Acc. No. U29668.
Ma WJ, Cheng S, Campbell C. Wright A, Furneaux (1996). Cloning and characterization of HuR, a ubiquitously expressed Elav-like pr
Fisher Paul B.
Magdalena Leszczyniecka
Baker & Botts LLP
Blanchard David J.
Helms Larry R.
Trustees of Columbia University in the City of New York
LandOfFree
Genes displaying enhanced expression during cellular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genes displaying enhanced expression during cellular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genes displaying enhanced expression during cellular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3467235